Elizabeth M. Anderson
CIK: 0001758247
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Sep 22, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct5K shares at avg. $192.54$960K - Sep 22, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct100 shares at avg. $195.15$20K - Sep 22, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.5K shares at avg. $194.59$292K - Sep 22, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct2.6K shares at avg. $193.44$512K - Sep 22, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct5.1K shares at avg. $1.12$6K - Sep 22, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct910 shares at avg. $191.85$175K - Jun 18, 2026RVMD
Revolution Medicines, Inc.
Award(A)Direct1.2K shares- - Jun 2, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct7.5K shares- - May 13, 2026INSM
INSMED Inc
Award(A)Direct3.3K shares- - Mar 4, 2026RVMD
Revolution Medicines, Inc.
Gift(G)Direct15K shares- - Mar 4, 2026RVMD
Revolution Medicines, Inc.
Gift(G)Indirect15K shares- - Nov 24, 2025INSM
INSMED Inc
Sale(S)Direct5K shares at avg. $204.58$1.0M - Nov 14, 2025INSM
INSMED Inc
Sale(S)Direct10K shares at avg. $195.87$2.0M - Jun 26, 2025RVMD
Revolution Medicines, Inc.
Award(A)Direct3.1K shares- - May 20, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct6.7K shares- - May 15, 2025INSM
INSMED Inc
Award(A)Direct5.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 22, 2026 |  RVMD Revolution Medicines, Inc. | Sale(S) | 4,985 | $192.54 | $959,805 | Direct |
| Sep 22, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 100 | $195.15 | $19,515 | Direct |
| Sep 22, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,500 | $194.59 | $291,883 | Direct |
| Sep 22, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,648 | $193.44 | $512,227 | Direct |
| Sep 22, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 5,070 | $1.12 | $5,678 | Direct |
| Sep 22, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 910 | $191.85 | $174,585 | Direct |
| Jun 18, 2026 | RVMD Revolution Medicines, Inc. | Award(A) | 1,191 | - | $0 | Direct |
| Jun 2, 2026 |  BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 7,490 | - | $0 | Direct |
| May 13, 2026 |  INSM INSMED Inc | Award(A) | 3,305 | - | $0 | Direct |
| Mar 4, 2026 | RVMD Revolution Medicines, Inc. | Gift(G) | 15,000 | - | $0 | Direct |
| Mar 4, 2026 | RVMD Revolution Medicines, Inc. | Gift(G) | 15,000 | - | $0 | Indirect |
| Nov 24, 2025 | INSM INSMED Inc | Sale(S) | 5,000 | $204.58 | $1,022,900 | Direct |
| Nov 14, 2025 | INSM INSMED Inc | Sale(S) | 10,000 | $195.87 | $1,958,700 | Direct |
| Jun 26, 2025 | RVMD Revolution Medicines, Inc. | Award(A) | 3,142 | - | - | Direct |
| May 20, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 6,650 | - | - | Direct |
| May 15, 2025 | INSM INSMED Inc | Award(A) | 5,058 | - | - | Direct |
1-16 of 16 transactions
About ANDERSON ELIZABETH M
ANDERSON ELIZABETH M (SEC CIK 0001758247) files insider reports with the SEC as Director of Revolution Medicines, Inc. (RVMD), Director of BIOMARIN PHARMACEUTICAL INC (BMRN) and Director of INSMED Inc (INSM).
Signal8 holds 10 ownership filings by ANDERSON ELIZABETH M, all Form 4s, filed between May 19, 2025 and Sep 24, 2026. Those filings report 16 transactions, from May 15, 2025 to Sep 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ANDERSON ELIZABETH M's filings is in REDWOOD CITY, CA.
Recent filings by ANDERSON ELIZABETH M
- Sep 22, 2026: Open-market sales of RVMD shares (4 lines, Form 4, code S).
- Sep 22, 2026: Option exercise of RVMD shares (Form 4, code M).
- Sep 22, 2026: Open-market sale of RVMD shares (Form 4, code S).
- Jun 18, 2026: Grant or award of RVMD shares (Form 4, code A).
- Jun 2, 2026: Grant or award of BMRN shares (Form 4, code A).
Other insiders filing for Revolution Medicines, Inc. (RVMD)
- Mancini Anthony
- Sandler Alan B., Chief Development Officer
- Cislini Jeff, SVP & General Counsel
- Kelsey Stephen Michael
- Horn Margaret A, Chief Operating Officer
- GOLDSMITH MARK A